There are 1076 resources available
678P - Ramucirumab plus Erlotinib (RAM+ERL) for advanced non-small cell lung cancer (NSCLC) harboring EGFR L858R mutation (L858R mut): A multicenter retrospective observational cohort study (REAL-SPEED)
Presenter: Masashi Ishihara
Session: Poster Display session
Resources:
Abstract
679P - Low-dose durvalumab in combination with etoposide and platinum as first-line treatment of patients with extensive-stage small cell lung cancer: A multi-institutional study from India
Presenter: Vivek Agarwala
Session: Poster Display session
Resources:
Abstract
680P - Sequential afatinib (AFA) to osimertinib (OSI) in EGFR-mutant NSCLC: An exploratory analysis of initial AFA dosage in Gio-Tag Japan, a multicenter prospective observational study
Presenter: Akito Hata
Session: Poster Display session
Resources:
Abstract
681P - Characterising the genomic landscape of advanced non-squamous NSCLC of Chinese: A territory-wide study in Hong Kong
Presenter: Aya El-Helali
Session: Poster Display session
Resources:
Abstract
682P - First-line serplulimab for advanced squamous non-small cell lung cancer: A multicenter, single-arm, real-world ASTRUM-004R study
Presenter: Bo Shen
Session: Poster Display session
Resources:
Abstract
683P - Aumolertinib plus anlotinib in advanced EGFR-mutant NSCLC with brain metastasis (Alot BRAIN): A single-arm, phase II study (GASTO 1063) (updated data)
Presenter: Li Kun Chen
Session: Poster Display session
Resources:
Abstract
684P - A phase I study of a common neoantigen srRNA vaccine (JCXH-212) with or without toripalimab in patients with non-small cell lung cancer(NSCLC)
Presenter: Hanxiao Chen
Session: Poster Display session
Resources:
Abstract
685P - Genomic profiles in EGFR mutant locally advanced or metastatic NSCLC patients after first-line osimertinib treatment failure: A real-world, multi-center prospective study in China
Presenter: Yuan-Kai Shi
Session: Poster Display session
Resources:
Abstract
686P - The predictive efficacy of tumor mutational burden for Immune Checkpoint Inhibitors in non-small cell lung cancer: A systematic review and meta-analysis of randomized controlled trials
Presenter: Min Ying
Session: Poster Display session
Resources:
Abstract
687P - Profile of actionable oncogenic alterations (AGA) among patients with advanced NSCLC in South India: A multicentric study
Presenter: Keechilat Pavithran
Session: Poster Display session
Resources:
Abstract